Genprex

United States
Kingston, Oklahoma, United States, 78712

Company profile

Genprex company profile

Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches.

Business identity

Contact email
[email protected]
Phone number
(512)537-7997
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2009-01-01, Year

Headquarters

Postal code
78712
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
12
Total equity funding
$95.5M
Last funding
Post IPO Equity / $3.4M / 2025-10-28
Last equity funding
Post IPO Equity / $3.4M
Investors
2
Lead investors
2
Founders
1
Articles
173
Exited on
2018-03-29

Founders and investors

Founders

Rodney Varner

Lead investors

Alliance Global PartnersInception Fund

Investors

Alliance Global PartnersInception Fund